Neuro2a-Luc Cells

Neuro-2a-Luc is a luciferase-expressing derivative of the Neuro-2a (N2a) mouse neuroblastoma cell line. Neuro-2a cells originate from murine neural crest-derived neuroblastoma tissue and are widely used as an in vitro model for neuronal differentiation, neurotoxicity studies, signal transduction research, and neuro-oncology investigations. Stable expression of a luciferase reporter enables sensitive, quantitative bioluminescent detection of viable cells and cellular activity, making Neuro-2a-Luc particularly useful for longitudinal monitoring in both in vitro and in vivo experimental systems. Depending on the reporter design, luciferase expression may be constitutive or linked to pathway-specific promoter activity.

Neuro-2a-Luc cells are commonly employed in applications involving tumor growth tracking, high-throughput drug screening, neural differentiation assays, and real-time assessment of therapeutic responses. In xenograft and metastasis models, luciferase-based bioluminescence imaging allows noninvasive monitoring of tumor burden and disease progression with high sensitivity. Neuro-2a-derived systems are also extensively used to study neuronal morphology, neurite outgrowth, apoptosis, oxidative stress, and mechanisms associated with neurodegenerative disease. The luciferase modification facilitates rapid quantitative analysis of cell proliferation, cytotoxicity, transcriptional activity, or pathway modulation in response to pharmacological or genetic perturbations.

As with other engineered reporter cell lines, experimental performance of Neuro-2a-Luc may depend on factors including luciferase construct integration site, promoter configuration, substrate compatibility, and stability of reporter expression over serial passage. Additional characterization data, including details regarding the luciferase variant, selection marker, and validation assays, may be required for highly specialized experimental applications.